Liver cancer is one of the major causes of cancer which requires accurate and early diagnosis for effective treatment. Conventional treatment often encounter challenges in early detection and tumor classification. Deep learning is a subset of AI and has shown immense potential in medical image analysis, offering improved accuracy for liver cancer detection and prediction. This review explores deep-learning models applied to liver cancer prediction, focusing on convolutional neural networks, recurrent neural networks, and ensemble methods. Key challenges, such as handling 3D medical imaging, data imbalance, and model interpretability, are discussed. Furthermore, this review highlights the clinical applications of deep learning models in tumor detection, segmentation, classification, and prognosis prediction. This review provides a detail overview of current deep learning techniques and their transformative impact on liver cancer diagnosis and treatment planning.
Introduction
I. INTRODUCTION
Liver cancer [1] remains a significant global health challenge, with Hepatocellular Carcinoma is the most common primary malignancy. Despite advancements in diagnostic and treatment modalities, liver cancer is frequently diagnosed at last stage, limiting treatment options and leading to high mortality rates. Detecting liver cancer in early stage and accurate tumor classification are crucial for improving prognosis and treatment outcomes; however, orthodox diagnostic approaches, such as imaging and biopsy, face limitations in sensitivity, especially during early stage detection. In recent years, deep learning (DL) has emerged as a transformative technology for analysis of medical images, offering significant improvements in the detection and classification of various cancers, including liver cancer. Deep learning, a branch of artificial intelligence (AI), is used to identify complex patterns in large datasets and has demonstrated superior performance in tasks such as cognizing images, segmentation, and disease classification. Its ability to automatically learn features from raw data has made it particularly valuable for medical imaging, where subtle differences in tissue and tumor characteristics can be difficult to identify using conventional methods. The goal of this study is to provide a review of the current advancements in liver cancer prediction using deep learning techniques. convolutional neural networks, recurrent neural networks, and ensemble methods have shown promise for various tasks, including liver tumor detection, segmentation, and classification. By automating the analysis of liver images using techniques such as computed tomography, magnetic resonance imaging, and ultrasound, deep learning models offer the potential to improve diagnostic precision and reduce human error in clinical practice. The introduction of deep learning into liver cancer diagnosis also brings new challenges, including the handling of high-dimensional medical imaging data, managing class imbalance owing to the rarity of some tumor types, and ensuring model interpretability for clinical use. This review will explore how current methods address these challenges and discuss the implications of integrating deep learning with other data types, such as genomic and clinical data, to enhance the predictive power of these models. As the field continues to advance, understanding the strengths and limitations of deep- learning approaches in liver cancer prediction is crucial for advancing research and clinical applications. This review highlights the progress, challenges, and future opportunities of utilizing deep learning for liver cancer prediction, with a focus on improving early detection, treatment planning, and patient outcomes.
II. RELATED LITERATURE WORK
A. Literature Survey
Convolutional Neural Networks [3] are a classified under deep learning models that have demonstrated remarkable success in image-based tasks, particularly in medical imaging for cancer prediction. Their architecture is designed to intuitively learn hierarchical features from input images, making them highly effective in detecting patterns in complex data, such as medical scans. In the context of liver cancer prediction, CNNs can be utilized for tasks such as tumor detection, segmentation, and classification.
Liver cancer detection has gained significant attention in medical imaging, and deep-learning approaches [4] have emerged as powerful tools for improving the accuracy and efficiency of diagnostics. This section reviews the key contributions in this field, focusing on various deep learning models and techniques used for liver cancer detection.
Traditional Machine Learning Approaches Early efforts in liver cancer detection predominantly relied on traditional machine learning methods, such as support vector machines random forests, and k-nearest neighbors. Researchers have used handcrafted features from medical imaging modalities, such as Computed Tomography, Magnetic Resonance Imaging, and ultrasound to classify liver tumors. Utilized texture-based features from CT scans combined with an SVM classifier to differentiate benign and malignant liver lesions. Although these approaches achieved modest success, their reliance on handcrafted features limited their generalizability and scalability.
Deep Learning in Medical Imaging Deep learning [5] has revolutionized medical imaging by automating feature extraction and improving classification performance. Convolutional Neural Networks (CNNs) are at the forefront of this shift which are implemented as CNN-based framework to automatically extract features from liver CT images for tumor classification, significantly outperforming traditional feature-based methods. Another notable study employees a deep learning architecture on MRI images, showing improved detection rates for hepatocellular carcinoma which is very common form of liver cancer.
Segmentation-Based Approaches are used to accurately segment the liver tumors for both diagnosis and treatment planning. Deep-learning models, particularly U-Net architectures, have been widely used for this task. In paper [7] developed a 3D U-Net model for liver tumor segmentation in CT scans, achieving state-of-the-art performance on the LiTS (liver tumor segmentation) dataset. Some researchers proposed a modified U-Net model combined with residual networks to improve the segmentation accuracy.
Transfer Learning and Pretrained Models mentioned in [4] specifies the challenges of obtaining large labeled medical datasets, transfer learning has been employed to leverage pretrained models on large general image datasets, such as ImageNet. Studies given in paper [8] have successfully adapted the ResNet and DenseNet architectures for liver cancer detection, achieving promising results with limited medical imaging data. This approach enables the application of deep learning to medical domains with small datasets by fine-tuning the pretrained models.
Attention Mechanisms and Hybrid Models [2] gives recent advancements in liver cancer detection and focus on integrating attention mechanisms into CNN architectures. introduced an attention-based network to focus on critical regions in liver images, thereby improving the accuracy of liver tumor detection. Other studies, such as combined CNNs with long short-term memory networks to model spatial and temporary dependencies in sequential MRI scans, thereby enhancing the ability of the model to detect early stage liver cancer.
III. FUTURE WORK
The integration of 3D imaging in liver cancer detection has enhanced possibilities for improvement of diagnostic accuracy and treatment planning. Although existing deep learning models have shown promise, several key challenges and opportunities remain. This section explores the potential directions for future research on 3D image-based liver cancer detection.
A. Enhanced 3D Imaging Data Availability
One of the major challenges in deep learning for liver cancer detection is the limited availability of large annotated 3D medical datasets. Unlike 2D images, 3D volumetric data from modalities, such as CT and MRI, are more complex and resource-intensive for collection and labeling.
Future work should focus on expanding publicly available 3D imaging datasets, including multi-center collaborations, to create more comprehensive and diverse collections. The development of automated annotation tools that leverage AI to assist radiologists in labeling liver lesions in 3D could significantly accelerate the dataset generation.
B. Advanced 3D Segmentation Models
Segmentation of liver tumors in 3D images is essential for accurate detection and treatment planning. Although U-Net- based architectures have been adapted for 3D data, significant room remains for improvement. Future research could explore more advanced architectures, such as 3D CNNs combined with attention mechanisms, to improve the segmentation accuracy. Additionally, integrating graph- based models or transformer architectures specifically designed for 3D data may enhance the ability of the model to capture complex spatial relationships within the liver.
C. 3D Model Interpretability and Explainability
Interpretability remains a significant challenge, particularly for complex 3D models. To gain clinicians’ trust, future studies should study on developing interpretable 3D deep learning models that can provide clear explanations for their predictions. Methods such as 3D saliency maps, Grad-CAM for 3D data, or attention mechanisms tailored to highlight critical regions in 3D scans can be developed to increase the transparency of predictions. This will allow radiologists and oncologists to better understand the basis of the AI model's decisions and ensure that it aligns with clinical reasoning.
Conclusion
Deep learning has significantly advanced liver cancer detection,[6] offering improved accuracy and automation in processing medical imaging data, such as Computed tomography and MRI scans. Modern techniques, including CNNs, U-Net architectures, and attention mechanisms, have outperformed traditional methods in tasks such as tumor segmentation and classification. The integration of 3D imaging and multimodal data provides further opportunities for enhanced diagnostic precision. However, challenges, such as limited annotated datasets, class imbalance, and the need for interpretability, remain. Addressing these issues, along with validating models in clinical settings, is crucial for translating deep-learning advancements into real-world medical practice. Despite these hurdles, deep learning shows great promise in revolutionizing liver cancer detection, paving the way for earlier diagnosis and personalized treatment.
References
[1] A. Das, S. S. Panda and S. Sabut, \"Detection of Liver Cancer using Optimized Techniques in CT Scan Images,\" 2018 International Conference on Applied Electromagnetics, Signal Processing and Communication (AESPC), Bhubaneswar, India, 2018, pp. 1-5
[2] X. Dong, Y. Zhou, L. Wang, J. Peng, Y. Lou and Y. Fan, \"Liver Cancer Detection Using Hybridized Fully Convolutional Neural Network Based on Deep Learning Framework,\" in IEEE Access, vol. 8, pp. 129889-129898, 2020
[3] K. Pathak and D. K. Singh, \"Convolutional Neural Networks based Liver Tumor Classification,\" 2022 International Conference on Augmented Intelligence and Sustainable Systems (ICAISS), Trichy,
India, 2022, pp. 171-177
[4] A. R and A. L, \"Effective Methods to Detect Liver Cancer Using CNN and Deep Learning Algorithms,\" 2023 International Conference on Advances in Computing, Communication and Applied Informatics (ACCAI), Chennai, India, 2023, pp. 1-
[5] K. M. Napte, A. Mahajan and S. Urooj, \"Automatic Liver Cancer Detection Using Deep Convolution Neural Network,\" in IEEE Access, vol. 11, pp. 94852-94862, 2023
[6] J. Dickson, A. Lincely and A. Nineta, \"A Dual Channel Multiscale Convolution U-Net Methodfor Liver Tumor Segmentation from Abdomen CT Images,\" 2022 International Conference on Sustainable Computing and Data Communication Systems (ICSCDS), Erode,
India, 2022 , pp. 1624-1628
[7] V. Chincholkar, S. Srivastava, A. Pawanarkar and S. Chaudhari, \"Deep Learning Techniques in Liver Segmentation: Evaluating U-Net, Attention U-Net, ResNet50, and ResUNet Models,\" 2024 14th International Conference on Cloud Computing, Data Science & Engineering (Confluence), Noida, India, 2024, pp. 775-779
[8] Y. Chai and H. Li, \"Segmentation of Liver and Its Tumor Based on U- Net,\" 2021 IEEE 5th Advanced Information Technology, Electronic and Automation Control Conference (IAEAC), Chongqing, China, 2021, pp. 208-211
[9] X. Li, S. Zhu, L. Song, S. Wang and Q. Liang, \"Algorithm for Segmentation of Liver Tumor Based on Improved U-Net Model,\" 2021 International Conference on Electronic Information Engineering and Computer Science (EIECS), Changchun, China, 2021, pp. 346-349
[10] B. Zhang, F. Wang, X. Chen, H. Lin and H. Huang, \"Liver Cancer Diagnosis in CT Employing U-Net,\" 2021 13th International Conference on Intelligent Human-Machine Systems and Cybernetics (IHMSC), Hangzhou, China, 2021, pp. 112-115